• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用计算机断层扫描对骨骼肌质量和肌肉质量进行术前评估:肝内胆管癌行肝切除术患者的肌肉减少症发生率

Preoperative Assessment of Skeletal Muscle Mass and Muscle Quality Using Computed Tomography: Incidence of Sarcopenia in Patients with Intrahepatic Cholangiocarcinoma Selected for Liver Resection.

作者信息

Ardito Francesco, Coppola Alessandro, Rinninella Emanuele, Razionale Francesco, Pulcini Gabriele, Carano Davide, Cintoni Marco, Mele Maria Cristina, Barbaro Brunella, Giuliante Felice

机构信息

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

出版信息

J Clin Med. 2022 Mar 10;11(6):1530. doi: 10.3390/jcm11061530.

DOI:10.3390/jcm11061530
PMID:35329856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8956038/
Abstract

Background: Sarcopenia is considered a predictor of poor postoperative and long-term results following liver resection for intrahepatic cholangiocarcinoma (ICC). The aim of our study was to assess the incidence of sarcopenia in patients resected for ICC and its relation to preoperative clinical factors. Methods: Patients resected for ICC in our unit, with available preoperative CT scans within one month before operation, were enrolled in the study. Skeletal muscle index (SMI) and skeletal muscle radiodensity (SMD) were assessed for each patient. Results: Thirty patients matched all inclusion criteria. Low SMI values were documented in 15 patients (50.0%), and low SMD values were documented in 10 patients (33.3%). SMI was significantly greater in males (p < 0.001). In patients who were underweight, the incidence of low SMI was significantly higher than that of high SMI (p = 0.031). In patients who were overweight/obese, the incidence of high SMI was significantly higher than that of low SMI (p = 0.003) and the incidence of low SMD was significantly higher than that of high SMD (p = 0.038). In the univariate analysis, no preoperative factors (clinical and tumor-related factors), in particular BMI, were found to be independent predictors of low SMI. Conclusions: The incidence of sarcopenia was 50.0% in patients selected for liver resection for ICC and was not related to the preoperative clinical factors. A multidisciplinary evaluation of the nutritional status is fundamental before liver resection in patients.

摘要

背景

肌肉减少症被认为是肝内胆管癌(ICC)肝切除术后不良预后和长期结果的预测指标。本研究的目的是评估接受ICC切除术患者的肌肉减少症发生率及其与术前临床因素的关系。方法:纳入在我院接受ICC切除术且术前1个月内有可用CT扫描的患者。评估每位患者的骨骼肌指数(SMI)和骨骼肌放射密度(SMD)。结果:30例患者符合所有纳入标准。15例患者(50.0%)记录到低SMI值,10例患者(33.3%)记录到低SMD值。男性的SMI显著更高(p < 0.001)。体重过轻的患者中,低SMI的发生率显著高于高SMI(p = 0.031)。超重/肥胖患者中,高SMI的发生率显著高于低SMI(p = 0.003),低SMD的发生率显著高于高SMD(p = 0.038)。在单因素分析中,未发现任何术前因素(临床和肿瘤相关因素),特别是BMI,是低SMI的独立预测因素。结论:接受ICC肝切除术患者的肌肉减少症发生率为50.0%,且与术前临床因素无关。对患者进行肝切除术前,多学科评估营养状况至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc5/8956038/b9edeb6f7b43/jcm-11-01530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc5/8956038/b9edeb6f7b43/jcm-11-01530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fc5/8956038/b9edeb6f7b43/jcm-11-01530-g001.jpg

相似文献

1
Preoperative Assessment of Skeletal Muscle Mass and Muscle Quality Using Computed Tomography: Incidence of Sarcopenia in Patients with Intrahepatic Cholangiocarcinoma Selected for Liver Resection.使用计算机断层扫描对骨骼肌质量和肌肉质量进行术前评估:肝内胆管癌行肝切除术患者的肌肉减少症发生率
J Clin Med. 2022 Mar 10;11(6):1530. doi: 10.3390/jcm11061530.
2
Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection.白蛋白-球蛋白评分与骨骼肌指数联合预测肝内胆管癌患者根治性切除术后的长期预后。
Clin Nutr. 2021 Jun;40(6):3891-3900. doi: 10.1016/j.clnu.2021.04.038. Epub 2021 May 3.
3
Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.骨骼肌质量、肌肉质量及内脏脂肪对肝内胆管癌切除术后结局的影响
Ann Surg Oncol. 2017 Apr;24(4):1037-1045. doi: 10.1245/s10434-016-5668-3. Epub 2016 Nov 11.
4
The association between low skeletal muscle mass and low skeletal muscle radiodensity with functional impairment, systemic inflammation, and reduced survival in patients with incurable cancer.不可治愈癌症患者中低骨骼肌质量和低骨骼肌放射密度与功能损害、全身炎症及生存率降低之间的关联。
JPEN J Parenter Enteral Nutr. 2023 Feb;47(2):265-275. doi: 10.1002/jpen.2460. Epub 2022 Nov 29.
5
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.胰腺癌一线化疗患者骨骼肌密度和肌肉减少症的临床意义:一项回顾性观察研究。
BMC Cancer. 2021 Jan 18;21(1):77. doi: 10.1186/s12885-020-07753-w.
6
Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma.术后早期骨骼肌量减少预测肝门周围胆管癌切除术后复发和不良生存。
BMC Cancer. 2022 Dec 28;22(1):1358. doi: 10.1186/s12885-022-10453-2.
7
Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.肌肉和脂肪组织参数与中低位直肠癌长期预后的相关性:一项回顾性队列研究。
Cancer Imaging. 2023 Jan 12;23(1):5. doi: 10.1186/s40644-022-00514-x.
8
Impact of Skeletal Muscle Mass Reduction on Long-term Survival After Radical Resection of Gastric Cancer.骨骼肌质量减少对胃癌根治术后长期生存的影响
Anticancer Res. 2023 Aug;43(8):3779-3786. doi: 10.21873/anticanres.16563.
9
Is skeletal muscle radiodensity able to indicate physical function impairment in older adults with gastrointestinal cancer?骨骼肌辐射密度能否预示胃肠道癌老年患者身体机能受损?
Exp Gerontol. 2019 Oct 1;125:110688. doi: 10.1016/j.exger.2019.110688. Epub 2019 Aug 9.
10
Importance of computed tomography muscle quality and continuous versus cut-off-based sarcopenia detection in major hepatic surgery.计算机断层扫描肌肉质量以及基于连续测量与基于截断值的肌肉减少症检测在大型肝脏手术中的重要性。
Ann Transl Med. 2022 Sep;10(18):955. doi: 10.21037/atm-21-5948.

引用本文的文献

1
Impact of preoperative prognostic factors on survival outcomes in intrahepatic cholangiocarcinoma: a retrospective cohort study.术前预后因素对肝内胆管癌生存结局的影响:一项回顾性队列研究。
Ann Surg Treat Res. 2025 Jun;108(6):345-351. doi: 10.4174/astr.2025.108.6.345. Epub 2025 Jun 2.
2
Beyond body mass index: Body composition profiling for perioperative risk stratification in intrahepatic cholangiocarcinoma patients.超越体重指数:体成分分析在肝内胆管细胞癌患者围手术期风险分层中的应用。
Cancer Rep (Hoboken). 2024 Sep;7(9):e2070. doi: 10.1002/cnr2.2070.
3
Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and meta-analysis.

本文引用的文献

1
Prediction Efficacy of Prognostic Nutritional Index and Albumin-Bilirubin Grade in Patients With Intrahepatic Cholangiocarcinoma After Radical Resection: A Multi-Institutional Analysis of 535 Patients.预后营养指数和白蛋白-胆红素分级对肝内胆管癌根治性切除术后患者的预测效能:一项对535例患者的多机构分析
Front Oncol. 2021 Dec 10;11:769696. doi: 10.3389/fonc.2021.769696. eCollection 2021.
2
A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy.一种基于肌肉减少症和影像组学的新型临床-影像组学模型,用于预测根治性肝切除术后肝内胆管癌的预后
Front Oncol. 2021 Nov 19;11:744311. doi: 10.3389/fonc.2021.744311. eCollection 2021.
3
手术治疗胆管癌中肌肉减少症的患病率及预测价值:一项全面综述和荟萃分析
Front Oncol. 2024 Mar 19;14:1363843. doi: 10.3389/fonc.2024.1363843. eCollection 2024.
4
Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy.术前控制营养状况(CONUT)评分是接受肝切除术治疗的胆管癌患者的独立预后因素。
Heliyon. 2023 Sep 29;9(10):e20473. doi: 10.1016/j.heliyon.2023.e20473. eCollection 2023 Oct.
5
Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study.高发地区肝内胆管细胞癌的流行趋势:基于人群的研究。
World J Gastroenterol. 2022 Jul 28;28(28):3695-3705. doi: 10.3748/wjg.v28.i28.3695.
6
Advances in Perioperative Nutrition.围手术期营养的进展
J Clin Med. 2022 Sep 1;11(17):5168. doi: 10.3390/jcm11175168.
7
Special Issue "Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments".特刊“肝胆胰癌症:诊断与治疗的新策略”
J Clin Med. 2022 Jul 2;11(13):3849. doi: 10.3390/jcm11133849.
Sarcopenia Predicts Cancer Mortality in Male but Not in Female Patients Undergoing Surgery for Cholangiocellular Carcinoma.
肌肉减少症可预测接受胆管细胞癌手术的男性患者的癌症死亡率,但对女性患者无此预测作用。
Cancers (Basel). 2021 Oct 26;13(21):5359. doi: 10.3390/cancers13215359.
4
Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment.肌肉减少症和肌脂肪变性作为晚期胆管癌姑息治疗患者的预后标志物
J Clin Med. 2021 Sep 23;10(19):4340. doi: 10.3390/jcm10194340.
5
The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.术后肝内胆管癌患者肌少症联合术前纤维蛋白原-白蛋白比值的预后价值:一项多中心前瞻性研究。
Cancer Med. 2021 Jul;10(14):4768-4780. doi: 10.1002/cam4.4035. Epub 2021 Jun 8.
6
Biliary tract cancer.胆道癌。
Lancet. 2021 Jan 30;397(10272):428-444. doi: 10.1016/S0140-6736(21)00153-7.
7
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
8
The impact of personalized nutritional support on postoperative outcome within the enhanced recovery after surgery (ERAS) program for liver resections: results from the NutriCatt protocol.个性化营养支持对肝切除术加速康复外科(ERAS)方案术后结局的影响:NutriCatt 方案的结果。
Updates Surg. 2020 Sep;72(3):681-691. doi: 10.1007/s13304-020-00787-6. Epub 2020 May 14.
9
Liver resection and transplantation for intrahepatic cholangiocarcinoma.肝切除术和肝移植治疗肝内胆管细胞癌。
J Hepatol. 2020 Feb;72(2):364-377. doi: 10.1016/j.jhep.2019.11.020.
10
The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?肌肉减少症在肝内胆管细胞癌患者中的作用:是预后标志物还是被夸大的参数?
Liver Int. 2019 Jul;39(7):1307-1314. doi: 10.1111/liv.14132. Epub 2019 May 24.